¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : À¯Çüº°, Á¦Ç° ¹× ¼­ºñ½ºº°, ¾à¹° À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Specimen Validity Testing Market Share, Size, Trends, Industry Analysis Report, By Type (Laboratory Testing, Rapid/POC Testing); By Product & Service; By Drug Type; By Indication; By End User; By Region; Segment Forecast, 2024 - 2032
»óǰÄÚµå : 1463133
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 119 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,964,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,367,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,771,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, °Ëü Ÿ´ç¼º ½ÃÇè ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 25¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¼¼°è ¼öÁØÀÇ ³²¿ë °Ë»ç ¿ä±¸ Áõ°¡´Â ½Ã·á Ÿ´ç¼º ½ÃÇè ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ëü Ÿ´ç¼º ½ÃÇèÀ¸·Î °³ÀÎÀÇ ¾à¹° ¼·Ãë ¹× ±âŸ À½½Ä ¼·Ã븦 È®ÀÎÇÒ ¼ö ÀÖ´Â °¡´É¼ºÀÌ ¹ý·üÀ̳ª ¹ýÀÇÇРȰµ¿¿¡¼­ÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °ËüÀÇ º¯Á¶°¡ ÇöÀúÇÏ°Ô Áõ°¡ÇÏ°í ¼Òº¯ °ËüÀÇ º¸¾È°ú ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö°í Àֱ⠶§¹®¿¡ °Ëü Ÿ´ç¼º ½ÃÇè µµ±¸·Î °ËüÀÇ ¹«°á¼ºÀ» È®ÀÎÇÏ´Â °ÍÀÌ ¹ý ÁýÇà°ü¿¡°Ô Àå·ÁµÇ°í ÀÖ½À´Ï´Ù.

ºÒ¼ø¹° ¿À¿°, Èñ¼®, º¯Á¶¸¦ °áÁ¤ÇÏ´Â ±â´ÉÀº Á÷Àå, ¾à¹° °Ë»ç, Çü»ç »ç¹ý ½Ã½ºÅÛ ¹× ¼¼°è ½ÃÀåÀÇ ´Ù¸¥ ºÎ¹®¿¡¼­ äÅÃµÈ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ºÎÁ¤È®ÇÑ ¾à¹° °Ë»ç °á°ú´Â ¸¹Àº »ç¶÷µé¿¡°Ô ÇØ¸¦ ³¢Ä¥ ¼ö Àֱ⠶§¹®¿¡ ¾à¹° °Ë»çÀÇ ½Å·Ú¼ºÀ» °áÁ¤Çϱâ À§ÇÑ ÀÇÇÐÀû °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

°Ëü Ÿ´ç¼º ½ÃÇèÀº Ç×°ø±â, öµµ, ÀÚµ¿Â÷ ¿î¼Û¾÷ÀÚ ¹× ±âŸ ¼ö¼Û°ú °°Àº ±ÔÁ¦µÈ ºÎ¼­ÀÇ ¹Ì¹¦ÇÑ Àå¼Ò¿¡ ÀÖ´Â °³Àο¡ ´ëÇØ ³Î¸® ½Ç½ÃµË´Ï´Ù. ±¹¹ÎÀÇ ¾ÈÀüÀ» º¸È£Çϱâ À§ÇØ È¿°úÀûÀÎ ¾à¹° °Ë»ç µµ±¸¸¦ äÅÃÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù, ±³ÅëºÎ(DOT)´Â ¼Òº¯ °Ë»ç¸¦ ´ëüÇϱâ À§ÇØ °æ±¸ ¾à¹° °Ë»ç¸¦ µµÀÔÇß½À´Ï´Ù.

Á÷Àå°ú ¿î¼Û¿¡ À־ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ ¼¼°èÀÇ ¾ö°ÝÇÑ ±ÔÁ¦´Â ½Ã·áÀÇ À¯È¿¼º °Ë»ç¿¡ ´Ù¾çÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡, ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸´Â ÇÕ¼º ¼Òº¯À» °áÁ¤ÇÏ°í »õ·Î¿î °Ëü Ÿ´ç¼º ½ÃÇèÀ» âÃâÇϱâ À§ÇÑ ÀáÀçÀû ±â¼úÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, WILEY ÀâÁö¿¡ °ÔÀçµÈ 2023³â ¿¬±¸¿¡¼­´Â ½Ã·á Á¶ÀÛ °Ë»ç¿¡ ´ëÇÑ °ËÅä°¡ ÀÌ·ç¾îÁ³½À´Ï´Ù.

½Ã·á À¯È¿¼º ½ÃÇè ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¼Òº¯ °Ë»ç ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ½ÇÇè½Ç ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó °Ë»ç½Ç °Ë»ç ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

Á¦Ç° ºÎ¹®Àº ¼Òº¯ °Ë»ç Ȱµ¿ÀÇ Áö¼ÓÀûÀÎ ¿ä±¸¿¡ µû¶ó °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.

Ç×¹ÙÀÌ·¯½ºÁ¦¹° ºÎ¹®Àº ¹ÙÀÌ·¯½º °¨¿°ÀÇ À¯ÇàÀ¸·Î ÀÎÇØ ´õ Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ¾à¹° ½ºÅ©¸®´× °Ë»çÀÇ ¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, À¯Çüº°

Á¦6Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÀûÀÀÁõº°

Á¦7Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼­ºñ½ºº°

Á¦8Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ¾àÁ¦ À¯Çüº°

Á¦9Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Áö¿ªº°

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global specimen validity testing market size is expected to reach USD 2.52 billion by 2032, according to a new study by Polaris Market Research. The report "Specimen Validity Testing Market Share, Size, Trends, Industry Analysis Report, By Type (Laboratory Testing, Rapid/POC Testing); By Product & Service; By Drug Type; By Indication; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising need for abuse testing at the global level highly drives the growth of the specimen validity testing market. The potential to identify the individual's drug intake and other food intake with specimen validity testing is facilitating its adoption in legal and forensic science activities. The significant rise in sample tampering and growing concerns about the security and safety of urine samples encouraged legal officers to check the integrity of the sample with specimen validity testing tools.

The capability to determine adulteration, dilution, and tampering is the primary factor contributing to its adoption in the workplace, drug testing, criminal justice system, and other sectors of the global marketplace. As incorrect drug test results can cause harm to several people, there is increasing demand for medical tests to determine the reliability of the drug tests.

Specimen validity testing is widely conducted on individuals in sensitive places in the regulated sector, such as airplanes, rail, motor carriers, and other transits. The government's initiatives to adopt effective drug testing tools to safeguard the population are likely to propel market growth. For instance, in May 2023, the Department of Transportation (DOT) introduced oral drug testing as an alternative to urine testing.

Stringent regulations globally to improve safety at the workplace and in transportation are anticipated to create diverse opportunities for specimen validity testing. Furthermore, ongoing research studies are exploring potential technologies to determine synthetic urine and create new specimen validity testing. For instance, a 2023 study published in WILEY magazine conducted a review on sample manipulation testing.

Specimen Validity Testing Market Report Highlights

The laboratory testing segment is anticipated to witness the highest growth due to the growing number of laboratories providing urine testing services.

The products segment accounted for the largest market share owing to the continuous need for urine testing activities.

The antiviral drugs segment is projected to experience a larger revenue share due to the prevalence of viral infections.

Asia Pacific is projected to register the fastest growth during the forecast period due to the rising number of drug screening tests in the region.

The global players include Abbott, Alfa Scientific Designs, Healgen Scientific, LabCorp, Nona Scientific Laboratory, Omega Laboratories, & Premier Biotech.

Polaris Market Research has segmented the specimen validity testing market report based on product & service, type, drug type, indication, end user and region:

Specimen Validity Testing, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Specimen Validity Testing, Product & Service Outlook (Revenue - USD Billion, 2019 - 2032)

Specimen Validity Testing, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

Specimen Validity Testing, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

Specimen Validity Testing, End User Outlook (Revenue - USD Billion, 2019 - 2032)

Specimen Validity Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Specimen Validity Testing Market Insights

5. Global Specimen Validity Testing Market, by Type

6. Global Specimen Validity Testing Market, by Indication

7. Global Specimen Validity Testing Market, by Product & Services

8. Global Specimen Validity Testing Market, by Drug Type

9. Global Specimen Validity Testing Market, by End-User

10. Global Specimen Validity Testing Market, by Geography

11. Competitive Landscape

12. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â